|
Type of isolates
|
Antimicrobial resistance profile of the isolates, frequency (%)
|
|---|
|
G−ve isolates
|
Profile
|
CN
|
AMC
|
Amp
|
CIP
|
SXT
|
CRO
|
F
| |
|---|
|
E. coli (19)
|
S
|
15 (78.9%)
|
16 (84.2%)
|
0 (0%)
|
14 (73.6%)
|
9 (47.4%)
|
17 (89.4%)
|
14 (73.6%)
| |
|
I
|
0 (0%)
|
1 (5.2%)
|
0 (0%)
|
1 (5.2%)
|
1 (5.2%)
|
1 (5.2%)
|
0 (0%)
| |
|
R
|
4 (21.1%)
|
2 (10.5%)
|
19 (100%)
|
4 (21.5%)
|
9 (47.4%)
|
1 (5.2%)
|
5 (26.6%)
| |
|
Klebsiella species (10)
|
S
|
7 (70%)
|
8 (80%)
|
0 (0%)
|
7 (70%)
|
6 (60%)
|
9 (90%)
|
6 (60%)
| |
|
I
|
0 (0%)
|
1 (10%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
| |
|
R
|
3 (30%)
|
1 (10%)
|
10 (100%)
|
3 (30%)
|
3 (30%)
|
1 (10%)
|
4 (40%)
| |
|
P. mirabilis (5)
|
S
|
4 (80%)
|
3 (60%)
|
0 (0%)
|
4 (80%)
|
3 (60%)
|
4 (80%)
|
4 (80%)
| |
|
I
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
| |
|
R
|
1 (20%)
| |
10 (100%)
|
1 (20%)
|
2 (40%)
|
1 (20%)
|
1 (20%)
| |
|
P. aeruginosa (3)
|
S
|
2 (66.7%)
|
1 (33.3%)
|
0 (0%)
|
1 (33.3%)
|
0 (0%)
|
2 (66.7%)
|
2 (66.7%)
| |
|
I
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
| |
|
R
|
1 (33.3%)
|
2 (66.7%)
|
3 (100%)
|
2 (66.7%)
|
3 (100%)
|
1 (33.3%)
|
1 (33.3%)
| |
|
C. freundii (1)
|
S
|
1 (100%)
|
1 (100%)
|
0 (0%)
|
1 (100%)
|
0 (0%)
|
1 (100%)
|
0 (0%)
| |
|
I
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
| |
|
R
|
0 (0%)
|
0 (0%)
|
1 (100%)
|
0 (0%)
|
1 (100%)
|
0 (0%)
|
1 (100%)
| |
|
Total (38)
|
S
|
29 (76.3%)
|
29 (76.3%)
|
0 (0%)
|
29 (77.1%)
|
18 (47.4%)
|
33 (86.8%)
|
26 (68.4%)
| |
|
I
|
0 (0%)
|
2 (5.2%)
|
0 (0%)
|
1 (2.6%)
|
1 (2.6%)
|
1 (2.6%)
|
0 (0%)
| |
|
R
|
9 (23.7%)
|
7 (18.4%)
|
38 (100%)
|
8 (21.1%)
|
19 (50%)
|
5 (13.2%)
|
12 (31.6%)
| |
|
Type of isolates
|
Antimicrobial resistance profile of the isolates, frequency (%)
|
|---|
|
G+ isolates
|
Profile
|
Pen
|
Ery
|
CL
|
CIP
|
SXT
|
CRO
|
F
|
VAN
|
|---|
|
S. aureus (10)
|
S
|
7 (70%)
|
6 (60%)
|
6 (60%)
|
8 (80%)
|
4 (40%)
|
9 (90%)
|
6 (60%)
|
10 (100%)
|
|
I
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
1 (10%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
|
R
|
3 (30%)
|
4 (40%)
|
4 (40%)
|
1 (10%)
|
6 (60%)
|
1 (10%)
|
4 (40%)
|
0 (0%)
|
|
S. saprophyticus (7)
|
S
|
5 (71.4%)
|
6 (85.7%)
|
6 (85.7%)
|
6 (85.7%)
|
2 (28.5%)
|
6 (85.7%)
|
6 (85.7%)
|
7 (100%)
|
|
I
|
0 (0%)
|
0 (0%)
|
1 (14.3%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
|
R
|
2 (28.6%)
|
1 (14.3%)
|
0 (0%)
|
1 (14.3%)
|
5 (71.5%)
|
1 (14.3%)
|
1 (14.3%)
|
0 (0%)
|
|
Total (17)
|
S
|
12 (70.5%)
|
12 (70.5%)
|
12 (70.5%)
|
14 (82.3%)
|
6 (35.3%)
|
15 (88.2%)
|
13 (76.5%)
|
17 (100%)
|
|
I
|
0 (0%)
|
1 (5.9%)
|
1 (5.9%)
|
1 (5.9%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
|
R
|
5 (29.5%)
|
4 (23.5%)
|
4 (23.5%)
|
2 (11.8%)
|
11 (64.7%)
|
3 (17.7%)
|
4 (23.5%)
|
0 (0%)
|
- CN gentamicin, AMC amoxicillin clavulanic acid, AMP ampicillin, CIP ciprofloxacin, SXT trimethoprim/sulfamethoxazole, CRO ceftriaxone, F nitrofurantoin, P penicillin, Ery erythromycin, CL clindamycin, VAN vancomycin, S sensitive, I intermediate, R resistant
